NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

iShares Biotechnology ETF logo
$199.54 -4.18 (-2.05%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$200.45 +0.91 (+0.46%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About iShares Biotechnology ETF (NASDAQ:IBB)

Advanced

Key Stats

Today's Range
$199.26
▼
$205.99
50-Day Range
$199.54
▼
$221.13
52-Week Range
$159.68
▼
$222.29
Volume
2.59 million shs
Average Volume
2.05 million shs
Market Capitalization
$10.62 billion
Assets Under Management
N/A
Dividend Yield
0.17%
Net Expense Ratio
0.44%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.44%0.55%0.57%0.54%0.53%
Other Expenses0.00%0.52%0.53%0.38%0.54%
Total Expense0.44%0.76%0.75%0.69%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.41%-0.67%
Net Expense0.44%0.58%0.63%0.61%0.60%
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBB ETF News Headlines

Seven bucks, yours for life: my Black Friday indicator deal
Base Camp Trading's Thomas Wood is giving away his proprietary Snapback Indicator for just $7 this Black Friday. Others paid $500 for it. It's a one-time price with no recurring billing, and the indicator is yours for life. It shows when it's time to sell or go short, and when it makes sense to buy. Check it for a potential Snapback before your next trade.tc pixel
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom (IBB)
AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology...
See More Headlines

IBB ETF - Frequently Asked Questions

iShares Biotechnology ETF's stock was trading at $168.77 on January 1st, 2026. Since then, IBB shares have increased by 18.2% and is now trading at $199.54.

iShares Biotechnology ETF shares split on the morning of Friday, December 1st 2017.The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

iShares Biotechnology ETF's top institutional shareholders include Goldman Sachs Group Inc. (6.50%), Healthcare of Ontario Pension Plan Trust Fund (1.15%), WestEnd Advisors LLC (1.08%) and Jefferies Financial Group Inc. (0.79%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Tesla (TSLA), Alibaba Group (BABA), Netflix (NFLX), Advanced Micro Devices (AMD) and Bank of America (BAC).

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
248

Fund Statistics

Assets Under Management
$0.00
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
1,627
Put Options
728
Call Options
899
Short Interest
10,056,315 shs

Miscellaneous

Beta
0.72
Creation Unit
50,000
Creation Fee
$614.00
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure


This page (NASDAQ:IBB) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners